Thailand's Emerging Role in the Cell and Gene Therapy Revolution: A Review of Progress and Potential

Simple item page
dc.contributor.authorViprakasit V.
dc.contributor.authorTulalamba W.
dc.contributor.authorSuksangpleng T.
dc.contributor.authorEkwattanakit S.
dc.contributor.correspondenceViprakasit V.
dc.contributor.otherMahidol University
dc.date.accessioned2026-04-20T18:16:05Z
dc.date.available2026-04-20T18:16:05Z
dc.date.issued2026-04-01
dc.description.abstractThis Perspective examines Thailand's role in cell and gene therapy, focusing on regulatory development and early clinical experience. These therapies are used in Thailand for β-thalassemia, or blood cancer, together with the evolving ATMP regulatory framework and the ATMP Sandbox Project. Rather than cataloguing global indications, we analyze how selected advances intersect with Thailand's health system, highlighting opportunities and constraints for its role as a regional site for ATMP research, manufacturing, and access in Southeast Asia.
dc.identifier.citationClinical and Translational Science Vol.19 No.4 (2026) , e70561
dc.identifier.doi10.1111/cts.70561
dc.identifier.eissn17528062
dc.identifier.pmid41979180
dc.identifier.scopus2-s2.0-105035678983
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/116309
dc.rights.holderSCOPUS
dc.subjectPharmacology, Toxicology and Pharmaceutics
dc.subjectNeuroscience
dc.subjectBiochemistry, Genetics and Molecular Biology
dc.subjectMedicine
dc.titleThailand's Emerging Role in the Cell and Gene Therapy Revolution: A Review of Progress and Potential
dc.typeReview
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105035678983&origin=inward
oaire.citation.issue4
oaire.citation.titleClinical and Translational Science
oaire.citation.volume19
oairecerif.author.affiliationSiriraj Hospital

Files

Collections

Scopus 2026